Myriad Genetics Inc., a Salt Lake City-based company focused on molecular diagnostics and precision medicine, has announced the election of Dr. Daniel M. Skovronsky to its board of directors. Skovronsky also was appointed to the Research and Product Innovation Committee of Myriad’s board. He serves as chief science officer and president of Lilly Research Laboratories at Eli Lilly and Co. He previously served as the founder and CEO of Avid Radiopharmaceuticals Inc. Myriad also announced the retirement of Walter “Wally” Gilbert as a director and vice chair of the board, effect in December. Gilbert, the company’s co-founder, has been on the board since March 1992.